[Pyelonephritis treatment in children in 2007: current literature review]

Cachat, François; Zeier, Gregory; Parvex, Paloma; Girardin, Eric; Von Vigier, Rodo; Konrad, Martin; Rudin, Christoph; Neuhaus, Thomas (2007). [Pyelonephritis treatment in children in 2007: current literature review]. Revue médicale suisse, 3(100), 510-2, 514. Genève: Médecine & Hygiène

Full text not available from this repository.

Four studies, including two being published as an abstract, have recently demonstrated the feasibility of oral treatment of pyelonephritis in children, with no increased risk of treatment failure, early urinary tract re-infection, or renal scars. To do so, the pediatrician must ensure that: (1) the patient does not appear toxic, has no vomiting; (2) there is no known severe obstructive or refluxing uropathy and (3) parents are deemed to be adherent to the treatment. If these criteria are fulfilled, the pediatrician can start an oral treatment with a 3rd generation cephalosporine for 10 to 14 days. Ambulatory follow-up is crucial, and persistance of fever after 3 days is a reason for a new outpatient visit, additional or supplementary imaging studies (renal ultrasonography) and eventually a switch to intravenous treatment.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
UniBE Contributor:	von Vigier, Rodo
ISSN:	0025-6749
ISBN:	17410936
Publisher:	Médecine & Hygiène
Language:	English
Submitter:	Anette van Dorland
Date Deposited:	04 Oct 2013 14:55
Last Modified:	05 Dec 2022 14:17
PubMed ID:	17410936
URI:	https://boris.unibe.ch/id/eprint/23455 (FactScience: 41883)